chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Feeling Dizziness and Light headed symptoms; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm right on 30Apr2021 at 09:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no past drug history. Concomitant medications included metoprolol tartrate (MANUFACTURER UNKNOWN) of 25mg and biotin (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 09Apr2021 at 08:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021 at 05:00, the patient experienced dizziness and light headed symptoms seemed to go away during except when moved fast tilt head back look up look to the left or right, in the mornings the dizziness came back and lasted for a few hours. The clinical outcome of dizziness and light headed was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: grogginess; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 02Apr2021 at 16:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included depression, type 2 diabetes mellitus from an unspecified date. Concomitant medications included sertraline hydrochloride (ZOLOFT), bupropion hydrochloride (WELLBUTRIN), insulin glargine (BASAGLAR), dulaglutide (TRULICITY) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 the patient experienced 4 weeks after 2nd dose, experienced continuous grogginess and fatigue. Lasting all day and was making it extremely difficult to work and be productive. The clinical outcome of the events groggy, fatigue was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Breast pain, Breast swelling
Clinical narrative: soreness in left breast; swelling of left breast; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 31Mar2021 at 09:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 28Apr2021 at 08:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any concomitant medications. The patient had no past drug history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced soreness in left breast and swelling of left breast. The clinical outcome of the event soreness in left breast and swelling of left breast was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Red itchy patches on torso; Red itchy patches on torso; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 16Apr2021 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 26Mar2021 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, two days after the second shot, the patient experienced red itchy patches on torso which started to fade two weeks later. The clinical outcome of the event red itchy patches on torso was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Back pain, Body temperature, Fatigue
Clinical narrative: Body aches through neck, shoulders, back; Body aches through neck, shoulders, back; Body aches through neck, shoulders, back; Temp of 100.4; Swollen lymph nodes in left armpit - very painful; swollen lymph nodes in left armpit - very painful; Tired - very tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0182) via an unspecified route of administration in the left arm on 02May2021 at 14:30 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medication. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0153) via an unspecified route of administration in the left  arm on 04Apr2021 at 14:15 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 03May2021 at 12:00, the patient was experienced body aches through neck, shoulders, back, temp of 100.4,swollen lymph nodes in left armpit - very painful and tired - very tired. The patient underwent lab tests and procedures which included body temperature on 03May2021 and the result was 100.4 (units unspecified). The clinical outcome of  body aches through neck, shoulders, back, temp of 100.4,swollen lymph nodes in left armpit - very painful and tired - very tired were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neck pain, Pyrexia
Clinical narrative: Body aches through neck, shoulders, back; Body aches through neck, shoulders, back; Body aches through neck, shoulders, back; Temp of 100.4; Swollen lymph nodes in left armpit - very painful; swollen lymph nodes in left armpit - very painful; Tired - very tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0182) via an unspecified route of administration in the left arm on 02May2021 at 14:30 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medication. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0153) via an unspecified route of administration in the left  arm on 04Apr2021 at 14:15 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 03May2021 at 12:00, the patient was experienced body aches through neck, shoulders, back, temp of 100.4,swollen lymph nodes in left armpit - very painful and tired - very tired. The patient underwent lab tests and procedures which included body temperature on 03May2021 and the result was 100.4 (units unspecified). The clinical outcome of  body aches through neck, shoulders, back, temp of 100.4,swollen lymph nodes in left armpit - very painful and tired - very tired were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pharyngeal swelling
Clinical narrative: Slight swollen/sore throat; Slight swollen/sore throat; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 03May2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included slight high blood pressure and medicated for hypothyroidism, under control. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 06:45, morning after second dose, the patient experienced slight swollen/sore throat that started getting better after couple hours. The clinical outcome of the events slight swollen/sore throat was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Suspected COVID-19, Vomiting
Clinical narrative: Have had Covid symptoms for 4 days.; Vomiting bile; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 30Apr2021 at 15:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and covid-19 in Jan2021. The patient had no known allergies. Concomitant medications included metformin hydrochloride (METFORMIN) used for unknown indication from unspecified dates. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 12:00 the patient experienced covid symptoms for 4 days, vomiting bile and loss of appetite. The clinical outcome of the events covid symptoms, vomiting bile and loss of appetite was not recovered at the time of this report.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Paraesthesia, Skin tightness
Clinical narrative: tingling, prickling bottom of right foot; progressed to intermittent paraesthesia/ prickling come and goes; burning sensations in limbs; tightening like a band around right calf, upper left arm, various nerve type issues like this; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161), via unspecified route of administration in the left arm on 10Apr2021 at 14:45 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. The patient had a history of allergy to sulfa drugs. Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 09:00, 18 hours after the vaccination the patient experienced tingling, prickling bottom of right foot, progressed to intermittent parasthesias, burning sensations in limbs, tightening like a band around right calf, upper left arm, various nerve type issues like this and prickling that comes and goes. The clinical outcome of the event tingling, prickling bottom of right foot, progressed to intermittent parasthesias, burning sensations in limbs, tightening like a band around right calf, upper left arm and  various nerve type issues was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, Rash
Clinical narrative: Fever; body aches; chills; headache; rash on left upper arm/shoulder area; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169), via an unspecified route of administration in the left arm on 26Apr2021 at 11:00(at the age of 47-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 11:00(at the age of 47-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 11:00, the patient experienced fever, body aches, chills, headache and rash on left upper arm/shoulder area. The clinical outcome of the events fever, body aches, chills, headache and rash on left upper arm/shoulder area was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Parosmia, Taste disorder
Clinical narrative: Partial loss of smell; Partial loss of taste; Things smelling bad that normally smell good; Things taste bad that normally taste good.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis and COVID-19; both from unknown dates. Concomitant medications included mesalazine (APRISO), azathioprine (IMURAN), prednisone (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC); all taken from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 19Mar2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced partial loss of smell as well as things smelled bad that normally smelled good and partial loss of taste, and things tasted bad that normally tasted good. The clinical outcome of the events partial loss of taste, and things tasted bad that normally tasted good and partial loss of smell as well as things smelled bad that normally smelled good was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymph node pain, Lymphadenopathy, Pain
Clinical narrative: Swollen lymph nodes in right arm pit; Painful lymph nodes in right arm pit; Body aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old-non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 02May2021 at 16:30(at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 06:00,the patient experienced swollen and painful lymph nodes in right arm pit and also experienced body aches and chills. The clinical outcome of the events swollen and painful lymph nodes in right arm pit, body aches and chills were recovering.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Headache, Pruritus
Clinical narrative: Stomach pain; Chills.; Fever; Diarrhoea; Continuing to have rashes; Itchy skin; Ongoing headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 18Apr2021 at 13:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included estradiol (ESTRADIOL) patch taken for an unknown indication from an unspecified date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 28Mar2021 at 01:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 19Apr2021 at 04:45, the patient experienced chills, fever, stomach pain, diarrhea for 3 days. On 19Apr2021 at 04:45, the patient also experienced rashes which continued at the time of reporting, itchy skin and an ongoing headache with no relief. The events resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included therapeutic massage and acupuncture. The clinical outcome of the events chills, fever, stomach pain and diarrhea were resolved on 22Apr2021. The clinical outcome of the events rashes, itchy skin and headache were not resolved at the time of report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Stomach pain; Chills.; Fever; Diarrhoea; Continuing to have rashes; Itchy skin; Ongoing headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 18Apr2021 at 13:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included estradiol (ESTRADIOL) patch taken for an unknown indication from an unspecified date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 28Mar2021 at 01:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 19Apr2021 at 04:45, the patient experienced chills, fever, stomach pain, diarrhea for 3 days. On 19Apr2021 at 04:45, the patient also experienced rashes which continued at the time of reporting, itchy skin and an ongoing headache with no relief. The events resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included therapeutic massage and acupuncture. The clinical outcome of the events chills, fever, stomach pain and diarrhea were resolved on 22Apr2021. The clinical outcome of the events rashes, itchy skin and headache were not resolved at the time of report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: swollen lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees; Aching lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 23Apr2021 at 15:30 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included some insect bites. Concomitant medications were not provided. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 02Apr2021 at 15:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient previously took oak and pine on an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced swollen and aching lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees. The clinical outcome of the events swollen and aching lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: Fever 100-101 F; Chills; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm left on 02May2021 at 13:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 11Apr2021 at 13:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 07:00, the patient woke up with chills and severe muscle aches after receiving second dose. On 03May2021 at 09:30, the patient experienced fever 100-101 F which lasted at least until the patient went to sleep that night at 21:00. The clinical outcomes of chills, muscle aches and fever 100-101 F were recovering.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Feeling of body temperature change, Vomiting
Clinical narrative: Threw up; started chilling; Started burning up late in night or early morning on 5/4.; Hot and cold through out the morning; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 03May2021 at 11:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 on an unspecified date. Concomitant medications included ramipril (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 the patient experienced started burning up late in night or early morning. On the same day around 06:45 started chilling and on the same day around 09:15 threw up. On the same day hot and cold through-out the morning. The clinical outcome of the events feeling hot, chills, vomiting, feeling hot and cold was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Severe muscle spasms in injection arm; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Mar2021 at 13:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included quadriplegia from an unknown date. The patient previously took sulfonamide for an unknown indication on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. On 28Mar2021, the patient experienced severe muscle spasms in injection arm. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event of muscle spasms was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Thrombophlebitis superficial, Ultrasound Doppler
Clinical narrative: superficial thrombophlebitis; This is a spontaneous report from a contactable nurse on behalf of a doctor and other health care professional via medical information team. A 55-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration in arm on 25Apr2021 (at the age of 55-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) taken for asthma, start and stop date were not reported. It was reported that he has a patient, male with no medical history. The patient got his second Pfizer COVID vaccine on 25Apr2021. The patient came in "yesterday" (03Jul2021) with superficial thrombophlebitis. He has a blood clot in his varicose vein. They did a doppler to rule out a DVT, and it was negative. The doctor was wondering if the patient was supposed to be treated with an anticoagulant. The doctor thought it was related to the vaccine. The patient noticed it "yesterday" and came into the office. The doppler was negative, but he has a positive superficial clot. The patient did come back "today" for follow up. They did not know the seriousness. The patient got the first vaccine on 30Mar2021 (at the age of 55-year-old). She does not know which arms the patient got the vaccine in. The outcome of superficial thrombophlebitis was reported as resolving.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Formication, Limb discomfort, Muscle fatigue
Clinical narrative: Muscle fatigue; 4 days later in the evening felt nauseous; Woken up daily since feeling like ants crawling under skin; Exhaustion (couldn't stay awake) after four hours; Heavy arm within one hour; Chills within 5 minutes; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 29Apr2021 at 12:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 12:45, within 5 minutes of vaccination, the patient experienced chills. On 29Apr2021 at 13:45, within one hour of vaccination, the patient experienced heavy arm. On 29Apr2021 at 16:45, four hours after vaccination, the patient experienced exhaustion (couldn't stay awake). Since 30Apr2021 at 04:00, the patient woke up daily at 04:00 feeling like ants crawling under skin which went away within 2 minutes. On 02May2021, 4 days after vaccination, in the evening, the patient felt nauseous and on 03May2021, on day 5 after vaccination, the patient experienced muscle fatigue. The clinical outcome of the events exhaustion, woken up daily since feeling like ants crawling under skin, heavy arm, chills, felt nauseous and muscle fatigue was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Muscle fatigue; 4 days later in the evening felt nauseous; Woken up daily since feeling like ants crawling under skin; Exhaustion (couldn't stay awake) after four hours; Heavy arm within one hour; Chills within 5 minutes; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 29Apr2021 at 12:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 12:45, within 5 minutes of vaccination, the patient experienced chills. On 29Apr2021 at 13:45, within one hour of vaccination, the patient experienced heavy arm. On 29Apr2021 at 16:45, four hours after vaccination, the patient experienced exhaustion (couldn't stay awake). Since 30Apr2021 at 04:00, the patient woke up daily at 04:00 feeling like ants crawling under skin which went away within 2 minutes. On 02May2021, 4 days after vaccination, in the evening, the patient felt nauseous and on 03May2021, on day 5 after vaccination, the patient experienced muscle fatigue. The clinical outcome of the events exhaustion, woken up daily since feeling like ants crawling under skin, heavy arm, chills, felt nauseous and muscle fatigue was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine, Pain in extremity, Paraesthesia
Clinical narrative: Migraine headaches for 15 days; Sore arm; Tingling feeling into finger tips; Fatigue for one week; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm right on 13Apr2021 at 10:45 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no past drug history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 07:15, the patient experienced sore arm with a tingling feeling into finger tips, fatigue for one week and migraine headaches for 15 days. Therapeutic measures were taken as a result of sore arm with a tingling feeling into finger tips, fatigue, migraine headaches and included treatment with Tylenol. The clinical outcome of the event fatigue was resolved on 21Apr2021, migraine headaches was resolved on 29Apr2021 , sore arm and tingling feeling into finger tips were resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Nausea, Vomiting
Clinical narrative: nausea; vomiting; Burning sensation in feet; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the arm left on 01May2021 at 12:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included vitiligo. Concomitant medications included naltrexone hydrochloride, bupropion hydrochloride (CONTRAVE) from an unknown date for an unknown indication. The patient previously took LEXAPRO. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 16:30 in the evening, the patient experienced burning sensation in feet. On 04May2021 in the morning, the patient experienced nausea and vomiting. The clinical outcome of the event burning sensation in feet, nausea and vomiting was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Decreased appetite, Fatigue, Pain
Clinical narrative: Body pain; Joint ache; Loss of appetite; Nagging cough; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 22Apr2021 at 08:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received first dose of 0.3 ml of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 01Apr2021 at 08:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 20:45, 12 hours after vaccination the patient experienced severe body pain, nagging cough, loss of appetite, fatigue and joint pain. It was reported that the joint ache and loss of appetite went away 48 hours after injection, but nagging cough and fatigue continue until an unknown date in May2021. The clinical outcome of the events loss of appetite and joint pain were resolved on 24Apr2021. The clinical outcome of the events nagging cough and fatigue were resolved on an unknown date in May2021 while the event body pain was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Pain
Clinical narrative: Body aches; Lymph node swelling under left arm; headache; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the arm left on 03May2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included losartan (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 02:00, one day after vaccination, the patient experienced body aches, lymph node swelling under left arm and headache. The clinical outcome of the events body aches, lymph node swelling under left arm and headache was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: full pinky finger as well as the ringer finger from the top knuckle up (finger-tip section) on right hand were tingly and numb; full pinky finger as well as the ringer finger from the top knuckle up (finger-tip section) on right hand were tingly and numb; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 29Apr2021 at 15:30 (at the age of 29-year-old)  as a single dose for COVID-19 immunization. The patient had no relevant medical history. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 07Apr2021 at 12:00 (at the age of 29-year-old) as a single dose for COVID-19 immunization. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021, the patient experienced tingling and numbness. Its reported that patient noticed the day after the 2nd dose, that full pinky finger as well as the ringer finger from the top knuckle up (finger-tip section) on right hand were tingly and numb. She kept trying to wiggle them to get more blood into them, but it continued to feel the way your foot does when it falls asleep. On (05/04/2021), it feels like the same feeling had come down right below the knuckle in the large portion of hand (bottom knuckle) from pinky, and a down to the 2nd knuckle in ring finger. The clinical outcome of the events of tingling and numbness was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Nausea, Oropharyngeal pain
Clinical narrative: Sore throat; Intense chills; Headache; Body aches; Dizziness; Nausea; Skin hurt when pressed on, kind of like a sunburn but without a rash; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the arm left on 30Apr2021 at 13:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any medication within two weeks of vaccination. The patient past drug history was reported that she was sensitive to prescription strength NSAIDS. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 09Apr2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 02:00 about 12 hours after the vaccination, the patient experienced intense chills, a headache, body aches, dizziness and nausea. she went back to sleep and when she woke up 4 hours later, her symptoms were gone and stayed away until that afternoon. A variation of the same symptoms returned: headache, intense chills, dizziness. She also noticed her skin was hurt when pressed on, kind of like a sunburn but without a rash. These symptoms again dissipated sometime while she was sleeping and felt fine the next morning (2 days after the shot). That night she felt like she was getting a sore throat and the next morning (3 days post shot) she woke up with a sore throat and by the afternoon she was dizzy again, but both symptoms dissipated by that night and have not returned (currently 4 days post shot). It was reported that her side effects were on and off for 3 days. The clinical outcome of the body aches and nausea was recovered on 01May2021 and of the intense chills, headache and skin hurt when pressed on, kind of like a sunburn but without a rash was recovered on 02May2021 and of the dizziness and sore throat was recovered on 03May2021.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Skin discomfort
Clinical narrative: Sore throat; Intense chills; Headache; Body aches; Dizziness; Nausea; Skin hurt when pressed on, kind of like a sunburn but without a rash; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the arm left on 30Apr2021 at 13:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any medication within two weeks of vaccination. The patient past drug history was reported that she was sensitive to prescription strength NSAIDS. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 09Apr2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 02:00 about 12 hours after the vaccination, the patient experienced intense chills, a headache, body aches, dizziness and nausea. she went back to sleep and when she woke up 4 hours later, her symptoms were gone and stayed away until that afternoon. A variation of the same symptoms returned: headache, intense chills, dizziness. She also noticed her skin was hurt when pressed on, kind of like a sunburn but without a rash. These symptoms again dissipated sometime while she was sleeping and felt fine the next morning (2 days after the shot). That night she felt like she was getting a sore throat and the next morning (3 days post shot) she woke up with a sore throat and by the afternoon she was dizzy again, but both symptoms dissipated by that night and have not returned (currently 4 days post shot). It was reported that her side effects were on and off for 3 days. The clinical outcome of the body aches and nausea was recovered on 01May2021 and of the intense chills, headache and skin hurt when pressed on, kind of like a sunburn but without a rash was recovered on 02May2021 and of the dizziness and sore throat was recovered on 03May2021.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node under left armpit.; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0169) via an unspecified route of administration in the  left arm on 17Apr2021 at 15:15 ( at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any past medication history. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 12:00, the patient experienced swollen lymph node under left armpit. The clinical outcome of the event swollen lymph node under left armpit was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.